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Objectives
We report the frequency of previous HIV testing at baseline in men who have sex with men (MSM)
who enrolled in an HIV self-testing (HIVST) randomized controlled trial [an HIV self-testing public
health intervention (SELPHI)].
Methods
Criteria for enrolment were age ≥ 16 years, being a man (including trans men) who ever had anal
intercourse (AI) with a man, not being known to be HIV positive and having consented to national
HIV database linkage. Using online survey baseline data (2017–2018), we assessed associations
with never having tested for HIV and not testing in the previous 6 months, among men who
reported at least two recent condomless AI (CAI) partners.
Results
A total of 10 111 men were randomized; the median age was 33 years [interquartile range (IQR)
26–44 years], 89% were white, 20% were born outside the UK, 0.8% were trans men, 47% were
degree educated, and 8% and 4% had ever used and were currently using pre-exposure
prophylaxis (PrEP), respectively. In the previous 3 months, 89% reported AI and 72% reported CAI
with at least one male partner. Overall, 17%, 33%, 54%, and 72% had tested for HIV in the last
3 months, 6 months, 12 months and 2 years, respectively; 13% had tested more than 2 years ago
and 15% had never tested. Among 3972 men reporting at least two recent CAI partners, only 22%
had tested in the previous 3 months. Region of residence and education level were independently
associated with recent HIV testing. Among current PrEP users, 15% had not tested in the previous
6 months.
Conclusions
Most men in SELPHI, particularly those reporting at least two CAI partners and current PrEP users,
were not testing in line with current UK recommendations. The results of the trial will inform
whether online promotion of HIVST addresses ongoing testing barriers.
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Introduction
There is clear value for people living with undiagnosed
HIV infection in ascertaining their HIV status so that
antiretroviral therapy (ART) can be initiated as early as
possible, which has benefits both for the health of the
individual [1,2] and for the wider population as a conse-
quence of reduced transmission risk [3,4]. However, low
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diagnosis rates remain the largest gap in terms of achiev-
ing the Joint United Nations Programme on HIV/AIDS
(UNAIDS) 90–90–90 goals, i.e. 90% of people with HIV
know their HIV status, 90% of people who know their
HIV-positive status access treatment, and 90% of people
on treatment have a suppressed viral load [5]. It is esti-
mated that 25% of the global population with HIV infec-
tion remain undiagnosed [6], which contributes
disproportionally to new transmissions.
In the UK, men who have sex with men (MSM) remain
the group at highest risk of HIV infection. In recent years,
however, there has been a reduction in HIV incidence in
MSM, largely as a consequence of increased frequent HIV
testing, rapid ART initiation following HIV diagnosis, and
expanded use of pre-exposure prophylaxis (PrEP) among
HIV-negative people [7,8,9]. The number of HIV diag-
noses in MSM fell from 3165 in 2014 to 1908 in 2018 (a
40% reduction) in the UK overall, and from 1523 to 736
in London (a 52% reduction) [8,9]. In 2018, each compo-
nent of the 90–90–90 target was exceeded, reaching
levels of 92–98–98 nationally [8].
Both international and national UK guidelines recom-
mend that MSM test annually for HIV and more frequently
if at higher risk, and it is recognized that increasing levels
of HIV testing in MSM remains key to reducing incidence
[10,11]. However, levels of ever and repeat HIV testing in
UK MSM do not meet these testing recommendations, with
studies reporting that 28% of MSM had never tested and
only 55% tested annually [12,13]. There are particular
issues around meeting the 3-monthly testing recommen-
dation for MSM at higher risk of HIV infection – those
who have had recent condomless anal intercourse (CAI)
with partners of unknown or serodifferent HIV status,
and/or use drugs during sex (chemsex). A 2016 study
reported that only 27% of men considered at “higher risk”
of HIV infection tested even 6-monthly (12). In addition,
it was estimated that 8.6% of MSM with HIV infection in
the UK remained undiagnosed in 2017 [8].
There has been increasing interest in the potential of
HIV self-testing (HIVST) to improve rates of ever and
repeat testing [14]. HIVST enables the person not only to
take the sample but also to process it themselves, so that,
at the time of testing, only they are aware of the result.
The potential advantage of HIVST is that it may address
structural and psycho-social barriers to testing [15-18],
including stigma and concerns around privacy and confi-
dentiality, and that it offers time saving and autonomy.
HIVST may enable MSM who test suboptimally to meet
norms around testing expectations which they might not
otherwise be able to meet [19]. HIVST is also a viable
means to support PrEP provision, where guidelines rec-
ommend 3-monthly HIV testing [20].
We report on the frequency of previous HIV testing
and associated factors at baseline in MSM (including
trans men) who opted to enrol in a large online HIV self-
testing randomized controlled trial (RCT) [an HIV self-
testing public health intervention (SELPHI)].
Methods
SELPHI was an internet based, open-label, randomized
controlled trial (2017–2019), which aimed to assess effec-
tiveness of providing free HIVST kits to increase HIV
diagnosis rates. The full trial methods have been pub-
lished previously [21]. In brief, SELPHI had a two-stage
randomization with a target of enrolling 10 000 partici-
pants. Randomization A took place at enrolment, with eli-
gible participants randomly allocated (in a 3:2 ratio) to the
offer of a free baseline HIV self-test (BT) versus no offer of
a free baseline HIV self-test (nBT) (Figure 1). Randomiza-
tion B was open only to participants who met further eli-
gibility criteria [21] and were randomized to receive
regular HIV testing reminders and the offer of a free HIV-
self test kit (RT) versus no regular self-test (nRT).
The SELPHI trial uses the BioSURETM (BioSure (UK) Ltd,
Nazeing, UK) HIVST kit, an antibody immunoassay detect-
ing HIV-1/2 antibodies from approximately 28 days after
infection, requiring a whole blood sample from a finger
prick. The HIVST kits were posted to participants by the
manufacturer, using an address provided at enrolment.
Participants were recruited to the trial through sexual
and social networking sites including Grindr, Hornet,
Recon, Scruff and community Facebook webpages using
advertising targeted to a broad spectrum of MSM and
trans people which has been described previously [22].
Criteria for enrolment were: (1) age ≥ 16 years, (2) being
resident in England or Wales, (3) being a man (including
trans men) or trans woman, (4) ever having had anal
intercourse (AI) with a man, (5) not being known to be
HIV positive, and (6) having provided consent to link to
the UK national HIV surveillance databases held by Pub-
lic Health England. Very few trans women were recruited
(n = 23) and they are not included in the current analysis
and will be reported on separately.
This paper reports baseline data provided prior to ran-
domization A. Data collected via an online survey at
baseline included sociodemographics (gender, sexual
identity, education, age, ethnicity and country of birth),
recent sexual behaviour (numbers of AI partners and CAI
partners in the previous 3 months), HIV testing history
(time of last test, number of tests in the last 12 months
and location of last test), sexually transmitted infection
(STI) testing history, and PrEP and post-exposure prophy-
laxis (PEP) use. Postcode was collected to enable delivery
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of the HIVST kit. This enabled calculation of (geodetic)
distance to the nearest genitourinary medicine (GUM)
(level 3) clinic using geographical information system
(GIS) mapping data. Travel time from a participant’s post-
code to the nearest GUM clinic (at peak hours on Monday
morning) was estimated for public transport (TRACC pro-
gramme; www.basemap.co.uk/tracc) and for driving (ARC-
GIS PRO programme; www.esri.com/en-us/arcgis/products/
arcgis-pro/resources). The analysis utilized public trans-
port time for London and driving time elsewhere.
The study protocol was approved by the UCL Research
Ethics Committee (REC) and informed consent was sought
from all participants (ref: 9233/001).
Statistical analysis
Analyses were performed in STATA version 15.1 (StataCorp
LLC, College Station, TX, USA). All analyses used data
collected at baseline and prior to randomization. Two
main analyses were performed. The first examined predic-
tors of never having tested for HIV among all partici-
pants. The second examined predictors of not having
tested in the 6 months prior to enrolment and included
only men who reported two or more CAI partners in the
3 months prior to enrolment. The latter group are recom-
mended to test quarterly according to UK guidelines,
whether or not they are receiving PrEP. However, we
used a conservative 6-month period for testing to allow
for delays in appointments or attending.
Quantitative variables were classified into between three
and five categories before associations with dependent
variables were examined. Logistic regression analyses were
based on participants with no missing data for any of the
included variables (complete case analysis). Although this
is less efficient than multiple imputation, the loss of effi-
ciency is minimal as the frequency of missing data was
low. For each variable, the category with the highest num-
ber of men was selected as the reference category. As eth-
nicity and being born outside of the UK were highly
correlated, only ethnicity was included in the multivariable
logistic regression models. Distance and travelling time to
the nearest GUM clinic were also highly correlated, and the
former was included in multivariable models. As the use of
PrEP and the use of PEP were almost perfect predictors
for having had an HIV test, these factors were not included
in the multivariable model. The multivariable logistic
Fig. 1 The HIV self-testing public health intervention trial schema.
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regression models included all listed variables, regardless
of the P-value from the univariable analysis, because par-
simony is an irrelevant consideration when the number of
observations greatly exceeds the number of variables.
Because of the very large sample size, many highly
statistically significant associations were found, even
when the size of the effect was modest. It is therefore
more informative to focus on estimates and confidence
intervals rather than P-values. Interpretation of the logis-
tic regression models is focussed on the adjusted odds
ratios, that is, after controlling for any confounding
effects of the other factors in the models.
Results
Baseline characteristics
Overall, 10 111 MSM were recruited to the trial, includ-
ing 81 (0.8%) trans men (Table 1). The median age of
participants was 33 years [interquartile range (IQR) 26–44
years]. Most men were of white British ethnicity (75.5%),
followed by white other (14.0%), with 19.7% reporting
that they had been born outside the UK. Most men identi-
fied as gay/homosexual (68.6%) followed by bisexual
(8.6%); a large proportion (22.2%) either did not complete
this question or selected the option “I don’t usually use a
term.” Only 1.6% of participants were of black ethnicity
and 4.3% of Asian ethnicity, despite recruitment strate-
gies aimed at increasing participation from these ethnic
groups. The majority of men recruited to the trial were
highly educated, 47.1% having a university education
and a further 11.2% reporting education beyond the age
of 18 years. Overall, 83.7% of men lived within 10 km of
a GUM clinic, with 72.3% having a travel time of ≤
20 min and 91.1% a travel time of ≤ 30 min.
In the previous 3 months, 89.5% of men reported that
they had had AI with at least one male partner and
27.9% reported AI with five or more partners in the pre-
vious 3 months. In terms of CAI partners, 70.0% of men
reported at least one male partner in the past 3 months
and 39.1% two or more partners. HIV or ART status of
the partners was not available.
Overall, 12.1% of men had ever used PEP and 3.8% cur-
rently used PrEP. As expected, current PrEP use was mainly
observed among men with at least two CAI partners in the
previous 3 months (7.6% used PrEP), compared to those
who did not report at least two CAI partners (1.4%). PrEP
was only available in England and Wales during SELPHI
enrolment through the Impact trial (England), through
implementation pilots (Wales) and from online pharmacies.
Of the 389 current users, 295 (75.8%) sourced PrEP via the
Table 1 Characteristics of participants at enrolment
Characteristic
All participants
(n = 10 111)
At least two CAI
partners in previous
3 months (n = 3952)
Region/country
London 2509 (24.8) 938 (23.7)
SE England 1430 (14.2) 562 (14.2)
NW England 1357 (13.4) 576 (14.6)
Yorkshire/Humber 856 (8.5) 344 (8.7)
SW England 841 (8.3) 332 (8.4)
E England 765 (7.6) 294 (7.4)
W Midlands 711 (7.0) 287 (7.3)
E Midlands 661 (6.5) 294 (7.4)
NE England 376 (3.7) 162 (4.1)
Wales 599 (5.9) 209 (7.3)
Distance to nearest GUM clinic
< 2 km 3014 (29.9) 1181 (30.0)
2–5 km 3895 (38.6) 1466 (37.2)
5–10 km 1743 (17.3) 708 (18.0)
≥ 10 km 1428 (14.2) 585 (14.8)
Travel time to nearest GUM clinic
< 10 min 3770 (37.5) 1487 (37.8)
10–20 min 3505 (34.8) 1355 (34.4)
≥ 20 min 2787 (27.7) 1091 (27.7)
Age
16–19 years 534 (5.3) 205 (5.2)
20–29 years 3301 (32.6) 1299 (32.9)
30–39 years 2883 (28.5) 1144 (28.9)
40–49 years 1919 (19.0) 770 (19.5)
≥ 50 years 1474 (14.6) 534 (13.5)
Sexual identity
Trans gender 81 (0.8) 32 (0.8)
Gay/homosexual 6936 (68.6) 2656 (67.2)
Bisexual 867 (8.6) 328 (8.3)
Straight/heterosexual 31 (0.3) 4 (0.1)
Other 33 (0.3) 12 (0.3)
Not stated† 2244 (22.2) 952 (24.1)
Ethnicity
White British 7594 (75.5) 3011 (76.6)
White other 1406 (14.0) 501 (21.7)
Black 161 (1.6) 79 (2.0)
Asian 437 (4.3) 155 (3.9)
Mixed 313 (3.1) 119 (3.0)
Other 150 (1.5) 66 (1.7)
Born outside UK 1993 (19.7) 735 (18.6)
Highest level of education
School 4168 (41.7) 1776 (45.6)
Further education 1119 (11.2) 465 (11.9)
University 4706 (47.1) 1655 (42.4)
No. of AI partners in previous 3 months
0 1064 (10.5) -
1 2140 (21.2) -
2–4 4081 (40.4) 1821 (46.1)
5–9 1894 (18.7) 1336 (33.8)
≥ 10 932 (9.2) 795 (20.1)
No. of CAI partners in previous 3 months
0 2828 (30.0) -
1 3330 (32.9) -
2–4 2943 (29.1) 2943 (74.5)
5–9 700 (6.9) 700 (17.7)
≥ 10 309 (3.1) 309 (7.8)
PrEP
Never 9310 (92.1) 3407 (86.3)
Past 406 (4.0) 239 (6.1)
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internet, 60 (15.4%) through participation in a trial, 12
(3.1%) by a private prescription, nine (2.3%) from a friend,
and 13 (3.3%) via other or unspecified means.
Sociodemographic characteristics were similar in men
who had at least two CAI partners in the previous
3 months compared to the overall sample, with the
exception of sexual risk behaviours (by definition) and
the use of PEP or PrEP.
HIV testing behaviours
Overall, 16.9% of men had tested for HIV in the 3 months
prior to trial entry, 33.2% in the previous 6 months, 54.1%
in the previous 12 months and 71.7% in the previous
2 years. It was reported that 13.0% of men had last tested
for HIV > 2 years prior to trial entry and 15.3% had never
tested for HIV (Table 2). Figure 2 shows the distribution of
time since last HIV test by geographical region.
Among men with at least two CAI partners in the pre-
vious 3 months, only 22.6% had tested for HIV in the
3 months prior to entry to the trial; 58.8% had not tested
in the previous 6 months and 11.5% had never tested
(Table 2). Overall, 61.2% of men reported that their last
HIV test was in a sexual health clinic, compared with
16.6% who had last tested via self-sampling and 6.7%
via a self-test. Men with at least two CAI partners in the
previous 3 months were slightly more likely to have had
their last HIV test in a sexual health clinic, but there were
no marked differences between the two groups for other
venues. Of the 389 current PrEP users, 382 completed the
question on time since last HIV test, of whom 56 (14.7%)
had not tested in the previous 6 months.
Associations with never having been tested for HIV
Never having tested was least common in London (8.3%)
and most common in Wales (27.0%), with proportions
ranging between 14.6% and 18.7% across the English
regions (Table 3). Never having tested was markedly
higher among men aged 16–19 years [45.7%; adjusted
odds ratio (OR) 3.54 compared with age 20–29 years].
Men aged 30–39 years were least likely to have never
tested (9.4%). Sexual identity was a powerful predictor
of never having tested, with an adjusted OR of 2.72 for
bisexual men (31.2%) and 9.50 for heterosexual men
(54.9%), compared with gay men, although the number
in the latter category was small (n = 31). The compara-
tively large group who declined to state their sexual
identity were slightly more likely never to have tested
compared with gay men (adjusted OR 1.23). There was a
gradient across level of education, with men whose high-
est level of education was to the age of 16 years only
having an adjusted OR of 1.52 compared with men who
attended university. There was no independent association
between never having tested for HIV and ethnicity or dis-
tance or journey time (not shown) to nearest sexual
health clinic. Neither previous PEP nor PrEP use was
included in these models, as ever HIV testing was nearly
ubiquitous in these groups (98.8% and 99.3%, respec-
tively); this finding was as expected, as HIV testing com-





(n = 10 111)
At least two CAI
partners in previous
3 months (n = 3952)
Current 389 (3.8) 301 (7.6)
Ever used PEP 1210 (12.1) 650 (16.6)
Values are n (%).
AI, anal intercourse; CAI, condomless anal intercourse; E, east; NE,
northeast; NW, northwest; SE, southeast; SW, southwest; W, west; GUM,
genitourinary medicine; PEP, post-exposure prophylaxis; PrEP, pre-expo-
sure prophylaxis.
Missing values (all participants, high-risk participants): region (6, 3), dis-
tance to clinic (31, 12), time to clinic (49, 19), ethnicity (50, 21), highest
level of education (118, 56), number of CAI partners (1, 0) PrEP (6, 5)
and PEP (83, 27). All other variables had complete data.
†
Either question not completed or response “I don’t usually use a term.”
Table 2 HIV testing characteristics at enrolment
Characteristic
All participants
(n = 10 111)
At least two CAI
partners in previous
3 months (n = 3952)
Never tested 1537 (15.3) 449 (11.5)
Time since last HIV test†
< 3 months 1695 (16.9) 884 (22.6)
3–5 months 1628 (16.3) 729 (18.6)
6–11 months 2093 (20.9) 822 (21.0)
12–23 months 1764 (17.6) 648 (16.6)
> 24 months 1297 (13.0) 382 (9.8)
No. of HIV tests in previous 12 months (if at least one)
1 2806 (52.3) 1116 (46.9)
2 1419 (26.8) 645 (27.1)
3 657 (12.7) 365 (15.3)
≥ 4 402 (7.6) 253 (10.6)
Venue of last HIV test
Sexual health clinic 5089 (61.2) 2235 (65.6)
Hospital 415 (5.0) 136 (4.0)
Community service 347 (4.2) 127 (3.7)
Self-sample 1380 (16.6) 504 (14.8)
Self-test 556 (6.7) 212 (6.2)
Bar/pub/club/sauna 114 (1.4) 58 (1.7)
GP 294 (3.5) 102 (3.0)
Other 121 (1.4) 32 (0.9)
Values are n (%).
CAI, condomless anal intercourse; GP, general practitioner.
Missing values (all participants, high-risk participants): time since last
HIV test (97, 38), number of tests in previous 12 months (141, 56), and
venue of last test (161, 59).
†
Denominator includes those never tested.
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Associations with not having recently tested among
men with at least two CAI partners in the previous
6 months
Similar, although not identical, associations were
observed in a multivariable logistic regression analysis of
not having had a recent (previous 6 months) test among
men with at least two CAI partners in the previous
3 months (Table 4). Geographical region remained a
strong predictor, although southeast England more clo-
sely resembled London in having a higher rate of recent
testing, and northeast England joined Wales as the lowest
ranking areas. A U-shaped relationship was again observed
for the effect of age, although it was somewhat less pro-
nounced, and the same strong gradient was evident for
educational level. There was a difference in testing rates
according to ethnicity, driven by higher rates of recent test-
ing among the white other group, who were mainly white
Europeans born outside of the UK (adjusted OR 0.77 com-
pared to white British). A weak association was observed
with distance to nearest GUM clinic, with a 17% lower
odds of not having recently tested among men living
within 2 km compared with those living between 2 and 5
km away. A noticeable finding was the lack of an associa-
tion between recent testing and sexual identity in this
group, in contrast to the analysis of never having tested.
Discussion
Among people enrolling in the SELPHI trial, the most
striking finding was the relatively low rate of HIV testing
among men with at least two CAI partners in the previ-
ous 3 months, who should, according to current UK rec-
ommendations on HIV testing frequency in MSM, be
testing at least quarterly [11]. This recommendation is
more frequent than current European guidance, which
recommends testing at least annually [23]. Almost 60%
of this high-risk group had not tested in the previous
6 months and 23% had not tested in the last 3 months.
Even higher levels of infrequent testing were observed in
certain regions (Wales and northeast England) and among
less well-educated men. Among the men who were taking
PrEP at the point of enrolment, approximately 15% had
not tested in the previous 6 months, most of whom had
sourced PrEP themselves [as a consequence of the current
National Health Service England (NHSE) policy of not
Fig. 2 Time since last HIV test by geographical region.
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making it freely available through the NHS]. This is con-
cerning, as regular testing is important in this group to
quickly identify breakthrough infections and initiate full
ART, and self-testing could fill an important gap in this
regard. It also indicates the importance of providing PrEP
through the NHS as part of a structured programme of
care with regular HIV and testing prior to prescription of
further supplies of PrEP.
In the UK, an estimated 3600 MSM were living with
undiagnosed HIV infection in 2018 [8]. Starting ART at
HIV diagnosis is now recommended for individual and
public health benefit [24], and attaining a durably sup-
pressed HIV viral load eliminates onward transmission of
the virus [3,4,25,26]. Therefore, reducing the time from
HIV infection to diagnosis in MSM remains a key objec-
tive for micro-elimination strategies, as up to 80% of all
HIV transmissions are estimated to derive from those who
are undiagnosed [7].
It is recognized that levels of ever or repeat HIV testing
in UK MSM, although increasing, remain lower than rec-
ommended in guidelines, particularly in MSM at
increased risk of HIV infection through CAI with multiple
partners [9,26]. Frequent HIV testing (3-monthly) is an
essential component for management of men taking PrEP.
We found that 33 men currently taking PrEP who had at
least two CAI partners in the previous 3 months had not
tested for HIV in the 6 months prior to entering the
study. A recent study used a discrete choice experiment
(DCE) design to determine whether MSM preferred a
remote HIV test option (self-sampling or self-testing) or
to test through a health care professional. In this study, a
small group of participants preferred HIV self-sampling
Table 3 Logistic regression analysis of never having tested for HIV (all participants)
Factor n (%) Unadjusted OR (95% CI) Adjusted OR (95% CI) P-value
Region/country
London 206 (8.3) 1.00 (ref) 1.00 < 0.001
SE England 206 (14.6) 1.89 (1.54, 2.32) 1.55 (1.24, 1.94)
NW England 213 (15.8) 2.08 (1.70, 2.55) 1.70 (1.36, 2.12)
Yorkshire/Humber 141 (16.6) 2.21 (1.75, 2.78) 1.74 (1.36, 2.24)
SW England 155 (18.7) 2.55 (2.03, 3.19) 1.99 (1.55, 2.55)
E England 127 (16.8) 2.23 (1.76, 2.83) 1.79 (1.38, 2.32)
W Midlands 132 (18.8) 2.56 (2.02, 3.24) 2.11 (1.64, 2.73)
E Midlands 127 (16.8) 2.74 (2.16, 3.48) 2.12 (1.63, 2.75)
NE England 64 (17.2) 2.31 (1.70, 3.13) 1.73 (1.25, 2.40)
Wales 161 (27.0) 4.10 (3.26, 5.16) 3.42 (2.66, 4.41)
Distance to nearest GUM clinic
< 2 km 390 (13.1) 0.88 (0.76, 1.01) 0.87 (0.75, 1.01) 0.19
2.1–5 km 566 (14.7) 1.00 (ref) 1.00
5.1–10 km 315 (18.2) 1.29 (1.11, 1.51) 1.03 (0.87, 1.21)
≥ 10.1 km 259 (18.4) 1.31 (1.11, 1.54) 1.02 (0.86, 1.22)
Age
16–19 years 241 (45.7) 4.03 (3.31, 4.89) 3.54 (2.88, 4.36) < 0.001
20–29 years 568 (17.3) 1.00 1.00
30–39 years 269 (9.4) 0.50 (0.43, 0.58) 0.53 (0.45, 0.62)
40–49 years 222 (11.7) 0.63 (0.54, 0.75) 0.66 (0.56, 0.79)
≥ 50 years 237 (16.3) 0.93 (0.79, 1.10) 0.89 (0.75, 1.06)
Sexual identity
Gay/homosexual 899 (13.0) 1.00 (ref) 1.00 < 0.001
Bisexual 267 (31.2) 3.02 (2.57, 3.54) 2.72 (2.29, 3.23)
Straight/heterosexual 17 (54.9) 8.10 (3.98, 16.5) 9.50 (4.40, 20.5)
Other 9 (27.3) 2.50 (1.16, 5.40) 2.03 (0.86, 4.76)
Not stated 345 (15.7) 1.24 (1.08, 1.42) 1.23 (1.07, 1.42)
Ethnicity
White British 1249 (16.6) 1.00 (ref) 1.00 0.35
White other 142 (10.2) 0.57 (0.48, 0.69) 0.82 (0.67, 1.00)
Black 25 (15.6) 0.93 (0.60. 1.43) 0.89 (0.56, 1.41)
Asian 62 (14.3) 0.84 (0.64, 1.11) 1.06 (0.78, 1.44)
Mixed 41 (13.1) 0.76 (0.54, 1.06) 0.80 (0.56, 1.15)
Other 14 (9.5) 0.53 (0.30, 0.92) 0.82 (0.45, 1.49)
Highest level of education
School 850 (20.6) 2.13 (1.89, 2.39) 1.52 (1.34, 1.73) < 0.001
Higher education 164 (14.8) 1.42 (1.18, 1.72) 1.29 (1.06, 1.57)
University 508 (10.9) 1.00 (ref) 1.00
The adjusted analysis was based on 9820 participants with complete data.
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(HIVSS) or HIVST and they were more likely to have
never previously tested, to be of non-white ethnicity and
also to be current PrEP users than those who preferred
facility-based testing [27]. Men were also reluctant to pay
for HIVST and preferred testing options that were free at
the point of delivery.
The motivations underlying testing behaviours in
MSM, in particular in men who are not testing in line
with the recommended frequency or who have never
tested, are complex. Lack of testing may be attributable
to structural barriers to obtaining an HIV test (e.g. clinics
being difficult to access because of time constraints or
capacity issues or distance); lack of knowledge about
how to obtain a test; low perceived risk of HIV infection
and individual psycho-social issues, including potential
fear of the result, fear of needles or medical procedures,
and issues around disclosure of homosexual activity and
perceived stigma [15,17,27,28]. Individuals enrolled in
this cohort in the knowledge that they would participate
in an RCT of HIVST. This suggests that HIVST is accept-
able to this cohort and may overcome some of these
structural and psychological barriers.
Table 4 Logistic regression analysis of not having an HIV test in the previous 6 months [for participants with at least two condomless anal
intercourse (CAI) partners in the previous 3 months]
Factor n (%) Unadjusted OR (95% CI) Adjusted OR (95% CI) P-value
Region/country
London 406 (43.8) 1.00 (ref) 1.00 < 0.001
SE England 305 (54.7) 1.55 (1.25, 1.91) 1.07 (0.84, 1.37)
NW England 364 (63.8) 2.26 (1.82, 2.80) 1.50 (1.19, 1.91)
Yorkshire/Humber 216 (63.7) 2.26 (1.74, 2.92) 1.37 (1.03, 1.83)
SW England 222 (67.3) 2.64 (2.03, 3.44) 1.67 (1.24, 2.25)
E England 189 (65.6) 2.45 (1.86, 3.23) 1.57 (1.15, 2.15)
W Midlands 185 (65.1) 2.40 (1.82, 3.17) 1.54 (1.14, 2.09)
E Midlands 148 (60.9) 2.00 (1.50, 2.67) 1.29 (0.93, 1.78)
NE England 118 (72.8) 3.45 (2.38, 4.99) 2.17 (1.46, 3.23)
Wales 146 (70.2) 3.03 (2.19, 4.19) 2.16 (1.51, 3.10)
Distance to nearest GUM clinic
< 2 km 610 (52.1) 0.79 (0.68, 0.92) 0.83 (0.70, 0.98) 0.03
2–5 km 840 (57.9) 1.00 (ref) 1.00
5–10 km 467 (66.4) 1.44 (1.19, 1.73) 1.13 (0.92, 1.38)
≥ 10 km 375 (64.8) 1.33 (1.09, 1.63) 1.02 (0.81, 1.27)
Age
16–19 years 143 (70.1) 1.72 (1.25, 2.37) 1.32 (0.94, 1.85) 0.06
20–29 years 745 (57.7) 1.00 (ref) 1.00
30–39 years 635 (55.9) 0.93 (0.79, 1.09) 1.19 (1.00, 1.42)
40–49 years 440 (58.4) 1.03 (0.86, 1.23) 1.23 (1.01, 1.50)
≥ 50 years 338 (64.0) 1.31 (1.06, 1.61) 1.33 (1.06, 1.68)
Sexual identity
Gay/homosexual 1510 (57.2) 1.00 (ref) 1.00 0.25
Bisexual 208 (64.0) 1.33 (1.04, 1.69) 1.09 (0.85, 1.42)
Straight/heterosexual 4 (100.0) ND ND
Other 8 (66.7) 1.49 (0.45, 4.98) 1.12 (0.33, 3.81)
Not stated 571 (61.1) 1.17 (1.01, 1.36) 1.19 (1.00, 1.41)
Ethnicity
White British 1848 (62.0) 1.00 (ref) 1 0.01
White other 224 (45.3) 0.51 (0.42, 0.62) 0.77 (0.62, 0.96)
Black 41 (51.9) 0.66 (0.42, 1.04) 0.89 (0.54, 1.45)
Asian 83 (53.9) 0.72 (0.52, 0.99) 1.19 (0.83, 1.72)
Mixed 71 (59.7) 0.91 (0.62, 1.32) 1.36 (0.90, 2.05)
Other 26 (40.0) 0.41 (0.24, 0.68) 0.54 (0.31, 0.93)
Highest level of education
School 1187 (67.6) 1.00 (ref) 1.00 < 0.001
Higher education 275 (59.8) 0.71 (0.58, 0.88) 0.83 (0.66, 1.04)
University 809 (49.2) 0.47 (0.41, 0.54) 0.62 (0.53, 0.72)
PrEP use
Never 2183 (64.6) 1.00 (ref) 1.00 < 0.001
Past 82 (34.6) 0.29 (0.22, 0.38) 0.32 (0.24, 0.43)
Current 33 (11.2) 0.07 (0.05, 0.10) 0.08 (0.06, 0.12)
The adjusted analysis was based on 3819 participants with complete data.
AI, anal intercourse; CAI, condomless anal intercourse; E, east; NE, northeast; NW, northwest; SE, southeast; SW, southwest; W, west; GUM, genitouri-
nary medicine; PEP, post-exposure prophylaxis; PrEP, pre-exposure prophylaxis; ND, not defined.
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Associations with lower levels of ever and repeat test-
ing in our study suggest that targeting promotion and
expanding testing opportunities in younger men and in
those with lower levels of education may improve access
to and uptake of HIV testing. Our results also suggest
that HIVST may provide a route for HIV testing for men
who are not gay identified, as these men were more
likely to have never tested for HIV prior to entering the
trial. This association of frequency of HIV testing and
sexual identity has been noted in other studies in MSM
which found that non-gay-identified MSM were least
likely to have tested previously for HIV [26]. There is
also a suggestion in our data that there are particular
barriers to HIV testing for those who live outside Lon-
don, most especially in Wales where provision of sexual
health services varies hugely between regions [28].
HIVST may play a role in meeting unmet HIV testing
needs in these areas.
There are several important considerations in interpret-
ing the results of our study. First, the trial participants
were, by definition, interested in HIV self-testing or may
have been interested in testing in any case and should
not be regarded as representative of the general MSM
population. However, our analysis is important in under-
standing the profile of individuals to whom self-testing
may have appeal. For example, when we designed the
trial we were uncertain if the online advertising would
mainly attract men who had never tested before (possibly
through unwillingness to engage with the health care
system) or who had tested before but saw self-testing as
a more convenient testing modality. The fact that 85% of
participants had previously tested points to the latter
explanation being more dominant. However, this percent-
age varied markedly according to certain characteristics.
A particularly strong effect was observed for age, with
almost one half of men aged 16–19 years not having
tested previously. Self-testing may be especially useful in
motivating younger men to initiate regular HIV testing.
Secondly, only limited and brief questions were asked
about previous HIV testing (time of previous test, number
of tests in the previous 12 months and venue of the pre-
vious test) and sexual history (number of AI and number
of CAI partners in the previous 3 months). Therefore, an
individual who last tested 3 years ago, say, may not have
been noncompliant with testing guidelines if he only
recently started having sex again after a long period of
celibacy or may have enrolled in SELPHI in order to
obtain an HIV test following recent risk behaviour. Simi-
larly, a partial explanation for the high rate of never test-
ing among young men is that their sexual debut may
have been a recent event. While it would have been
desirable to ask more detailed questions, ideally linking
historical testing behaviour to historical sexual beha-
viour, the priority was to keep the enrolment process
short to maximize recruitment to the trial. Thirdly, we
recruited low numbers of black minority ethnic and trans
men, who are key groups at risk of HIV infection, which
may make the results less generalizable [29,30].
In summary, we found that men with at least two CAI
partners had been testing at lower than recommended levels
at entry to an online HIVST trial. The current UK HIV test-
ing policy in MSM focusses on increasing the rate of annual
testing among all MSM, including those at lower risk of
HIV infection [i.e. younger men, much older men (≥ 65
years old) and non-gay-identified MSM] [8]. Instead, the
results of our study suggest that promotion of more frequent
testing among the groups most at risk of infection should
be prioritized in order to reduce the time between infection
and diagnosis. Our study suggests that free provision of
HIVST could play a role in overcoming barriers to frequent
HIV testing, and that online ordering for postal delivery is a
feasible and acceptable means of delivery for MSM.
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